Amelia Cline joined Pipeline in November 2021 as Head of Regulatory Affairs. Amelia brings over 12 years of industry experience supporting drug development for small molecules and biologics in Regulatory Affairs. Amelia has worked on over 20 clinical programs in all stages of development across multiple indications, including oncology, inflammatory diseases, CNS, and hematology. Most recently, Amelia led regulatory activities at Applied Molecular Transport (AMT). Prior to AMT Amelia held a variety of regulatory roles at Peregrine Pharmaceuticals, Mast Therapeutics and UCSD. She has also served as a regulatory consultant for a variety of biotech companies and led operational activities at a central IRB, where her interest in regulatory started.